ATH 14.3% 0.3¢ alterity therapeutics limited

imagine extension trial proceeds, page-12

  1. 152 Posts.
    Here is a website with some interesting statistics on research:

    http://www.ciscrp.org/professional/facts_pat.html

    And here is an interesting stat from this page in regards to retention rates:

    4.In an analysis of 25,855 study volunteers in the United States 73.2% of participants completed Overall clinical trials (Phases I-IV), 75.4% completed Phase I clinical trials, 69.7% completed Phase II/III clinical trials and 93.8% completed Phase IV clinical trials. (CenterWatch, 2003)

    83% retention in a phase II trial is considerable to say the least, compared to the average of 69.7%. What is more is that this retention fact pertains to completion of original trial! What Prana has achieved is 95% retention for full duration of the trial and 83% retention into an extension trial. I deem this highly encouraging in my humble opinion.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.18K 3.279M

Buyers (Bids)

No. Vol. Price($)
38 52064257 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126697935 22
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.